(Total Views: 648)
Posted On: 03/09/2022 1:23:47 PM
Post# of 145858
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: Goosebumps #119765
Quote:
I thought we already completed the phase 3 trial for mono with great results. Our goal was a label extension after we achieved combo HIV approval
Monotherapy CD03 was a trial with no comparator arm. A phase 3 double blinded, placebo controlled trial needs to be done in monotherapy in order to get a label extension. All of this because the FDA wanted a combo trial done before we could get a green light on a pivotal monotherapy trial. Which was BS because the placebo arm would have been with HAART therapy so no harm would come to those patients as a result or none more than the HAART they were already taking would have done.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)